Phage therapy is the next generation of medical treatment against bacterial infections, according to Jonathan Solomon, CEO of BiomX and may hold to key to curing chronic diseases such as inflammatory bowel disease (IBD) and cancer. Over 1.5 million Americans suffer from IBD and according to CBO Assaf Oron, the numbers of cases are growing rapidly.
BiomX was founded by scientists with expertise in bacteriophages, or phages, which is the natural viruses that fight bacteria in the body. By sequencing strains of harmful bacteria, BiomX hopes to create effective phages to provide targeted and specific treatment of diseases caused by bacteria.
The process of identifying the correct phage to attack bacteria is very complex and requires the collection of bacteria strains from many people and test various phages for effectiveness against the various strains of bacteria. BiomX is also working on ways to manipulate and strengthen phages to fight against bacteria.